FDA Investigator: Tiara N. Brown-Crosen

- Tiara N. Brown-Crosen first started conducting FDA inspections in 2015, with the last inspection in 2019. Over that time, Tiara N. Brown-Crosen has conducted 50 inspections at 47 companies across 50 sites.

Get Tiara Brown-Crosen's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Reliance Life Sciences, Navi Mumbai | 2019

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483

FDA 483 Bal Pharma Limited- Unit 2, Bangalore | 2018

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483

FDA 483 Wuhan Biocause Pharmaceutical Development Co., Ltd., Wuhan | 2018

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483

FDA 483 Fujian Kerui Pharmaceutical Co., Ltd., Fuqing | 2018

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483

FDA 483 Prevention Health Sciences Inc., Raleigh | 2018

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483

FDA 483 Lonza AG, Visp | 2017

Out-of-stock
Tiara N. Brown-Crosen
Human Drug Form 483